Saturday 17 October 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 15.4%, EPS was flat, free cash flow grew 77.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
21.95
0.62
−2.75%
Follow KIDS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 4 | 4 | 3 |
+8 more TTM periods Free account |
| (11.36%) | (11.57%) | (11.31%) | (12.67%) | ||
| (7.83%) | (8.16%) | (8.08%) | (9.28%) | ||
ROIC |
(4.77%) | (5.94%) | (6.44%) | (7.30%) | |
Return on Tangible Assets |
(16.01%) | (16.05%) | (15.26%) | (17.29%) | |
Average Days of Receivables |
88.03 | 81.66 | 83.14 | 82.30 | |
Free Cash Flow per Share |
(0.08) | (0.53) | (0.68) | (1.25) | |
Free Cash Flow |
(1.83) | (12.62) | (15.96) | (29.43) | |
Capital Expenditures |
(9.24) | (8.64) | (11.11) | (10.25) | |
| Other line items | |||||
Cash ROIC |
(0.38%) | (2.59%) | (3.15%) | (5.82%) | |
Accounts Receivable Turnover |
4.40 | 4.94 | 4.91 | 4.83 | |
Accounts Payable Turnover |
3.81 | 3.86 | 4.60 | 6.84 | |
Inventory Turnover |
0.51 | 0.52 | 0.51 | 0.51 | |
Average Days of Payables |
121.90 | 109.77 | 107.67 | 40.67 | |
Days of Inventory on Hand |
754.06 | 746.72 | 766.77 | 731.29 | |
Tax Rate |
0.01 | 0.00 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
3.62% | 3.69% | 3.85% | 4.29% | |
Selling, General and Administrative Expense of Revenue |
79.04% | 80.23% | 81.47% | 81.54% | |
Share Based Compensation of Revenue |
6.66% | 7.36% | 7.52% | 7.59% | |
Interest Coverage |
(3.58) | (5.25) | (6.54) | (8.38) | |
Operating CF/Net income |
(0.19) | 0.10 | 0.12 | 0.42 | |
Depreciation/Fixed assets |
0.59 | 0.58 | 0.56 | 0.50 | |
Capex/Depreciation |
(0.32) | (0.31) | (0.40) | (0.40) | |
Revenue per Share |
10.51 | 10.27 | 10.07 | 9.65 | |
Operating CF per Share |
0.31 | (0.17) | (0.21) | (0.81) | |
Capex per Share |
(0.38) | (0.36) | (0.47) | (0.43) | |
Capex to Sales |
0.04 | 0.04 | 0.05 | 0.05 |
Columns are period end dates